InsiderFlow

Justin B. Klee

AMLX

Justin B. Klee serves as director, officer: Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

15 trades

$12.19M

Net Position

Net Seller

$12.19M

Companies Traded

1

AMLX

Active Period

Mar 2023 – Nov 2026

15 total trades

Most Recent

Sell AMLX

Nov 12, 2026 · $2.98M

Justin B. Klee's Insider Trading at Amylyx Pharmaceuticals, Inc. (AMLX)

Buys

0 · $0.00

Sells

15 · $12.19M

Total Shares Bought

0

Total Shares Sold

645,371

AMLX Price Chart
Loading chart...
DateTypeValue
Nov 12, 2026 Sell$2.98M
Sep 14, 2026 Sell$980.3K
Feb 4, 2026 Sell$227.6K
Feb 2, 2026 Sell$227.6K
Jan 20, 2026 Sell$1.88M
Jan 15, 2026 Sell$1.88M
Jan 8, 2026 Sell$85.6K
Sep 30, 2025 Sell$431.0K
Mar 31, 2025 Sell$74.5K
Mar 3, 2025 Sell$14.5K
Feb 3, 2025 Sell$41.1K
Jan 6, 2025 Sell$30.2K
Sep 30, 2024 Sell$59.4K
Jan 9, 2024 Sell$95.4K
Mar 16, 2023 Sell$3.19M